Digitisation | November 14, 2023
BioPhy launches AI platform to accelerate the drug development market
The company has raised US$4.5 million in funding for its AI operating system
The company has raised US$4.5 million in funding for its AI operating system
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
European operations' revenue grew 58.4% to Rs 599.7 crore
US business grew by +12.8% YoY
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23
The collaboration brings a seamless digital experience to more formulators worldwide
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Total transaction value of the divestment is Rs. 3,660 million
PhytoSquene now available for clinical and commercial use
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
